The metagenomics market to see novel tests for disease diagnosis

The global metagenomics market size is expected to reach USD 1.40 billion by 2025, exhibiting a CAGR of 16.6 percent, projects Grand View Research. Rise in demand for microbial screening in food and chemical industries for commercial applications, coupled with rapid developments in bioinformatics and biotechnology tools, is anticipated to accelerate market growth in the coming years. Key market participants are striving to capitalize potential avenues in the market by addressing challenges faced by research entities pertaining to data assembly, identification, and verification of rare metagenomes. Furthermore, companies operating in the molecular diagnostics and genomics arena are playing a crucial role in this market by partnering with metagenomics companies for development of novel tests for disease diagnosis. For instance, in September 2017, IDbyDNA, Inc. and ARUP Laboratories co-developed Explify Respiratory – a metagenomic NGS test for screening of respiratory infections. The anticipated launch of many such novel tests is projected to boost the market.